Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

SLN Silence Therapeutics PLC

18,90

-0,10 (-0,53%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:03:31

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Silence Therapeutics (NASDAQ:SLN)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Silence Therapeutics Charts.

Silence Therapeutics (NASDAQ:SLN)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Silence Therapeutics Charts.

News Silence Therapeutics PLC

Silence Therapeutics to Present at Jefferies Global Healthcare Conference
Donnerstag 30 Mai 2024 (3 Wochen vor) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 17 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 16 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress
Donnerstag 16 Mai 2024 (1 Monat vor) • Business Wire

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 14 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form DEL AM - Delaying amendment
Mittwoch 8 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
Dienstag 30 April 2024 (2 Monate vor) • Business Wire

Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
Montag 29 April 2024 (2 Monate vor) • Business Wire

Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
Montag 8 April 2024 (2 Monate vor) • Business Wire

Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
Mittwoch 13 März 2024 (3 Monate vor) • Business Wire

Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb
Mittwoch 13 März 2024 (3 Monate vor) • IH Market News

Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
Mittwoch 13 März 2024 (3 Monate vor) • Business Wire

Weitere Silence Therapeutics PLC News-Artikel

Nova Ljubljanska banka d...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen